GS Medical USA Announces FY'2012 Record Year-end Sales Growth Of Over 130% Over FY'2011
SOQUEL, Calif., March 20, 2013 /PRNewswire/ -- GS Medical USA, LLC (GSM), today announced record breaking year-end financial results. Unprecedented sales growth of seven consecutive quarters and increased market presence is attributed to strategic sales leadership, astute product engineering and an extensive higher-quality national distribution network.
"We continue to emphasize a dynamic focus on the sales and service of making our surgeon customers and hospitals our number one priority, which is made possible through our expanding USA distribution network," states Shawn McQuinn, VP of Sales & Marketing USA. "Our ability to accommodate all special circumstances, including surgeon instrument requirements and last minute demands, has significantly contributed to GSM's twenty-one months of continued growth." GSM's fiscal growth is partly attributed to the recent successful launch of the AnyPlus® MIS NX system, a system designed and manufactured in the USA.
Looking forward, GSM has several products in the development stage and under FDA review. These would include a Stand-Alone ALIF and ACIF implants, posterior cervical screw, hook, and occipital fixation device, as well as an ACDF plate to name a few. "We are optimistic that our expanding product portfolio, in addition to our 2013 increased surgeon education programs and exhibition at major Ortho/Neuro Spine meetings, will allow GSM the stature and opportunity to continue to exceed its growth expectations," comments CEO John Stephani. GSM will remain supportive of ongoing efforts of Spine Societies, in addition to focusing on advancements in minimally invasive technology.
Cognizant of sensitive pricing thresholds within healthcare economics, "GS Medical serves as a champion for this expanding spine market by meeting the demand for high-quality, cost-effective medical devices including user friendly solutions for cervical, thoracolumbar and deformity surgery, as well as minimally invasive approaches and spinal fracture fixation," remarks McQuinn. GSM continues to drive research and development efforts by infusing capital to bring innovative and expanding product lines to market. Most impressively, GSM is poised to experience a triple digit growth in the 2013.Please visit GSM at the upcoming AAOS (booth #3208) and AANS (booth #1314) conferences.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts